These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 10895860
21. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients. Halimi S. Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635 [No Abstract] [Full Text] [Related]
23. [Knack of treatment with oral hypoglycemic drugs in the elderly]. Komatsu M, Hashizume K. Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454 [Abstract] [Full Text] [Related]
24. Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both? Khan U, Seetharaman S, Merchant R. Am J Med; 2017 Jan; 130(1):e29-e30. PubMed ID: 27593606 [No Abstract] [Full Text] [Related]
25. [Combined insulin and sulfonylurea treatment in diabetes mellitus]. Ravina A, Minuhin O. Harefuah; 1986 Jan 01; 110(1):11-4. PubMed ID: 3514394 [No Abstract] [Full Text] [Related]
26. When to use insulin in the maturity onset diabetic. Tattersall RB, Scott AR. Postgrad Med J; 1987 Oct 01; 63(744):859-64. PubMed ID: 3328848 [No Abstract] [Full Text] [Related]
27. [Clinical efficacy of glimepiride]. Kaneko T, Sakamoto N. Nihon Rinsho; 1997 Nov 01; 55 Suppl():152-7. PubMed ID: 9434460 [No Abstract] [Full Text] [Related]
30. [Not Available]. Viardot A. Ther Umsch; 2017 Nov 01; 74(8):423-431. PubMed ID: 29461148 [No Abstract] [Full Text] [Related]
31. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep 01; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related]
32. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E, Schnell O. Diabetes Care; 2008 Feb 01; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
33. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. Williams SA, Shi L, Brenneman SK, Johnson JC, Wegner JC, Fonseca V. J Diabetes Complications; 2012 Feb 01; 26(5):399-406. PubMed ID: 22699113 [Abstract] [Full Text] [Related]
34. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes. Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR. Diabet Med; 2009 Jul 01; 26(7):665-72. PubMed ID: 19573114 [Abstract] [Full Text] [Related]
36. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL, Wolf SL, Kabadi UM. Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835 [Abstract] [Full Text] [Related]
37. Hypoglycemia in type 2 diabetes: understanding patients' and physicians' knowledge and experience. Fisher SJ, Huang X, Pawaskar M, Witt EA, Rajpathak S, Shankar RR, Inzucchi SE. Endocrine; 2018 Jun 12; 60(3):435-444. PubMed ID: 29460218 [Abstract] [Full Text] [Related]